Insulin-dependent diabetes mellitus (IDDM) susceptibility determinants are known to be associated with both HLA-DR3 and -DR4. We monitored the inheritance of HLA-DR alleles in 37 families in which IDDM affected one parent and at least one offspring in order to try to learn more about the modes of inheritance of IDDM determinants. Ninetyseven insulin-dependent diabetics whose parents did not have diabetes and 158 nondiabetics were used as control groups for estimates of DR allele frequencies in the overall diabetic and general populations. The proportion of diabetic parents who transmitted DR4 to diabetic offspring (78%) was significantly higher (P < 0.001) than the gene frequency of DR4 in the overall diabetic population (43%). The proportion of nondiabetic parents who transmitted DR4 to diabetic offspring (22%) was not significantly different from the gene frequency of DR4 in the nondiabetic population (16%), but it was significantly lower (P < 0.05) than the gene frequency in the overall IDDM population. These proportions suggest that inheritance of the DR4-associated IDDM susceptibility determinant is not recessive, because in recessive inheritance expression of a trait depends on each parent contributing a susceptibility determinant. The proportions of diabetic and nondiabetic parents who transmitted the DR allele associated with the susceptibility determinant would then equal one another. The transmission of predominantly DR4 from affected parents to affected offspring suggests that susceptibility to IDDM is inherited primarily via a single dose of a potent determinant associated with DR4, as in dominant inheritance. When DR3 was transmitted at all it was usually by the nondiabetic parent.
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Only 8% of diabetic parents transmitted DR3 but 35% of nondiabetic parents transmitted DR3. The proportion of nondiabetic parents who transmitted DR3 was similar to the gene frequency of DR3 in the overall diabetic population (29%), but it was significantly higher than the gene frequency ofDR3 in the nondiabetic population (15%; P < 0.005). The percentage of diabetic offspring with the genotype DR3DR4 (35%) was identical to the percentage of individuals in the overall IDDM population with this genotype (35%). Numerous population data indicate that the DR3DR4 genotype carries a higher relative risk for IDDM than any other genotype, which suggests synergism between the DR3-and DR4-associated determinants.
The family data reported here support this synergism but suggest that the DR4-associated determinant can give substantial susceptibility independent of the DR3-associated determinant and that the DR3-associated determinant is often expressed as enhancing susceptibility in the presence of the dominant DR4-associated determinant.
The mode of inheritance of insulin-dependent diabetes mellitus (IDDM) has long been of interest, but recently, after it was discovered that the disorder is associated with the HLA complex on chromosome 6, its inheritance has become the subject of lively debate (1, 2) . Different HLA studies have variously suggested that the inheritance of IDDM is dominant, recessive, and intermediate between dominant and recessive (one dose of an HLA-associated allele gives susceptibility to IDDM, but two doses of the allele increases susceptibility markedly) and that there is genetic heterogeneity in IDDM (3-6). There does seem to be general agreement that only susceptibility to IDDM is inherited and that currently unknown environmental factors, either nonspecific or specific, are important in triggering destruction by lymphocytes of the insulin-producing cells in the islets of Langerhans.
The disagreement over the inheritance of susceptibility to IDDM may stem in part from the enormous polymorphism of the HLA region and from the complexity of the HLA associations in IDDM. The HLA-DR locus, which is the HLA locus that has shown the strongest association with IDDM, has at least 10 alleles and, unlike most other HLA-associated disorders, not one but two DR alleles, DR3 and DR4, are associated with IDDM. Most studies show that DR3 and DR4 each has a frequency of 20-30% in the general population, whereas 50-60% of subjects with IDDM are DR3-positive and 65-80% are DR4-positive. In total, >95% of subjects with IDDM are positive for DR3 and/or DR4, and interestingly, the DR3DR4 genotype has a higher relative risk for IDDM than any other genotype (7, 8) . It is now widely appreciated that the DR3 and DR4 data are incompatible with any simple form of inheritance. Instead, it is believed that these data suggest that there are two separate diabetes susceptibility determinants-one associated with DR3 and another associated with DR4, and that these determinants often interact to enhance susceptibility to IDDM (4, 7, 8) .
To learn more about the modes of inheritance of the DR3-and DR4-associated determinants in IDDM, we monitored the transmission of DR alleles in families with IDDM in one parent and at least one offspring. Despite the many studies of HLA in IDDM, no study has been directed specifically at the inheritance patterns of DR alleles in families with a diabetic parent and diabetic offspring.
There should be a high probability that the DR allele transmitted to a diabetic offspring by a diabetic parent (and possibly also by a nondiabetic parent) is associated with an IDDM susceptibility allele. If the inheritance of a susceptibility determinant that is associated with a particular DR allele is recessive, then the proportions of diabetic and nondiabetic parents transmitting the DR allele would be equal. In addition, these proportions should equal the gene frequency of the DR allele in the overall IDDM population. Surprisingly, among the DR alleles transmitted from the diabetic parents to their diabetic offspring, DR4 was overrepresented and DR3 was extremely underrepresented. When DR3 was transmitted at all, it was usually transmitted Abbreviation: IDDM, insulin-dependent diabetes mellitus. tTo whom reprint requests should be addressed.
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by the nondiabetic parent. This pattern of inheritance suggests that susceptibility to IDDM is inherited primarily via a single dose of a potent determinant associated with DR4 as in dominant inheritance of the determinant. The family and population data of the current study support the synergism between the DR3-and DR4-associated determinants that was previously suggested by population data, but they suggest that the DR3-associated determinant is relatively weak and is often expressed as enhancing susceptibility in the presence of the DR4-associated determinant.
SUBJECTS AND METHODS
Subjects were typed for all World Health Organization recognized and provisional HLA-A, -B, -C, -DR, -DQ, -Bw4/Bw6, and -DRw52/DRw53 specificities with standard methodology (9) . Only the data on DR are reported here. The additional data were used to discern parental haplotypes when necessary.
Thirty-seven Caucasian families in which a parent and at least one offspring had typical IDDM were ascertained. Of the 44 diabetic offspring in 37 families, 28 were males, and of the 37 diabetic parents, 29 were fathers. Each diabetic offspring and diabetic parent required and received insulin from diagnosis onward. All families except one were ascertained through an offspring and 10 offspring (nos. 2a, 3, 4, 5, 7b, 9, 15, 19, 30, and 33) were ascertained through the 2-year survey of IDDM described below. The only requirement we imposed was that the families have a parent and at least one offspring with IDDM. These families were all of this type of family known to the first author and every family consented to participate in the study. Because two nondiabetic parents were unavailable (nlos. 8 and 29), their DR phenotypes were inferred from the DR allele transmitted to their offspring. Each parent was classified as heterozygous for the allele because the probability of homozygosity is low (<5%).
A group of unrelated subjects with IDDM and a group of nondiabetics were HLA typed to obtain estimates of allele frequencies among the overall diabetic and nondiabetic populations. One hundred and seven diabetics were randomly selected for HLA typing from a group of 278 Caucasian subjects reported in a prospective 2- (10) ; and the distribution of DR antigens among the 107 subjects with IDDM did not differ appreciably from data on IDDM reported by others (7, 8, (11) (12) (13) (14) (15) . Data on the 97 subjects with IDDM and without diabetic parents were used to estimate the frequencies of the various DR alleles in the overall diabetic population and were estimated as follows: 52 subjects were DR3-positive, which includes five subjects who typed positive for only DR3; 77 subjects were DR4-positive, which includes six subjects who typed positive for only DR4. Each subject who typed positive for only DR3 or DR4 was considered to be homozygous, which may not be the case, but which actually overestimates slightly the frequencies of DR3 and DR4 in the diabetic population, making the comparisons with the family data more conservative. The DR4-positive (30%) was much higher than that in the overall IDDM population (2%), and the percentage of nondiabetic parents who were DR4-positive was much lower than that in the overall IDDM population (79%) (P < 0.0001).
DISCUSSION
The increased homozygosity for DR4 among the diabetic parents may explain a small part of the high frequency of diabetic parents who transmitted DR4 to their diabetic offspring, since the homozygous DR4 individual could, of course, transmit only DR4. It is possible that some of these parents may have two doses of the DR4-associated susceptibility determinant. This idea is supported by the fact that in three of the four families with multiple affected offspring, the diabetic parent happened to be homozygous for DR4 and transmitted different DR4-containing haplotypes to different offspring.
The increased homozygosity for DR4 among the diabetic offspring (14% versus 6% of IDDM subjects) may be an indication that two doses of a DR4-associated determinant give greater susceptibility to IDDM than a single dose of the determinant. On the other hand, since neither the proportion of nondiabetic parents who transmitted DR4 (22%) nor the percentage of DR4 homozygous diabetic offspring (17%) was significantly greater than the gene frequency of DR4 in the overall nondiabetic population (16%), it is possible that some or most of the DR4 alleles received from the nondiabetic parents were not in linkage with a susceptibility determinant for IDDM. This idea is supported by HLA-B data. Both our population data and published data (16) show that "extended" DR4 haplotypes containing Bw6O or Bw62 (which are also in linkage disequilibrium with DR4 in the general population) are associated with IDDM. None of the five diabetic offspring who received DR4 from both parents received Bw6O or Bw62 from the nondiabetic parent. However, 16 of the 29 diabetic parents who transmitted DR4 to their diabetic offspring also transmitted Bw6O or Bw62.
A predominance of diabetic fathers versus diabetic mothers with diabetic offspring, as was seen in the present study, has been previously noticed and discussed thoroughly (17, 18) . Our data do not suggest that the transmission of DR4 is primarily limited to diabetic fathers. Six of the eight diabetic mothers transmitted DR4 to their diabetic offspring-a proportion that is similar to that of diabetic fathers who transmitted DR4.
The only slightly higher ratio of DR4 in IDDM than DR3 to their respective frequencies in the general population does not suggest that the mode of inheritance of the DR3-associated susceptibility gene is any different from that of the DR4-associated susceptibility gene. However, the high proportion of diabetic parents who transmitted DR4 (78%) and the low proportion who transmitted DR3 (8%) ( Table 2) probably indicates that a single dose of a gene associated with DR4 is capable of giving susceptibility to IDDM, as in dominant inheritance. If the inheritance of the HLA-related susceptibility to IDDM were simple recessive, it would be necessary for the nondiabetic parent to transmit the same susceptibility gene to the diabetic offspring as that transmitted by the diabetic parent. Therefore, the proportions of nondiabetic parents and diabetic parents who transmitted the DR allele associated with the susceptibility determinant would be similar. Since this did not occur, simple recessive inheritance can be ruled out. As mentioned above, only 22% of the nondiabetic parents transmitted DR4, and this proportion was not significantly different from the gene frequency of DR4 in the nondiabetic population (16%). The fact that the It is noteworthy that when DR3 was transmitted to the diabetic offspring it was usually transmitted by the nondiabetic parent. The proportion of nondiabetic parents who transmitted DR3 (35%) was about equal to the gene frequency ofDR3 in the overall diabetic population (29%) ( Table 2 ). The transmission of DR3 primarily by the nondiabetic parent and the transmission of DR4 primarily by the diabetic parent raises the question of what is the relationship between the DR3-associated and the DR4-associated susceptibility determinants. The percentage of diabetic offspring who were positive for both DR3 and DR4 (35%) was identical to that of the overall IDDM population (35%), but each of these percentages was much higher than the percentage of the DR3IpR4 genotype in the overall nondiabetic population (5%) ( Table 3 ). Since the DR3DR4 genotype is associated with a higher relative risk for IDDM than any other phenotype (7, 8, (11) (12) (13) (14) (15) , it is tempting to speculate that the role of the DR3-associated determinant is often to augment the susceptibility conferred by the DR4-associated determinant.
Studies of families with multiple siblings with IDDM have shown that two HLA haplotypes are shared by affected siblings much more often than expected (19) (20) (21) (26, 27) . IDDM in this syndrome may represent a small subset (<5%) of all cases of IDDM (27) . Although the etiology is autoimmune, it may differ in some way from that of the majority of cases of IDDM.
If it is accepted that DR3 is associated with a risk for IDDM, independent of DR4, then the three-allele or heterogeneity model of Rotter and co-workers (28, 29) partially fits with the current hypothesis. They proposed that there are three forms of IDDM-a form associated with DR3, a form associated with DR4, and a form associated with both alleles. Our results suggest that the two latter forms, if they are indeed very different from each other, are numerically the major forms of IDDM, which is in keeping with the predictions of Rotter and co-workers. However, since DR3 is more often than not associated with DR4 in IDDM and the DR4-associated determinant is apparently independently capable of giving susceptibility to IDDM, it is possible that the so-called form of IDDM associated with both the DR3-and the DR4-related genes should be viewed as a subset of a major form determined primarily by the DR4-associated susceptibility gene.
In summary, our data on families with diabetes in two generations indicate that a major IDDM susceptibility determinant is associated with DR4 and was usually transmitted by the diabetic parent, and that another susceptibility determinant is associated with DR3 and was usually transmitted by the nondiabetic parent, when it was transmitted at all. The determinant associated with DR4 appears to give susceptibility independently of other susceptibility determinants, as in dominant inheritance. In light of population data and the family data reported here as well, the determinant associated with DR3 appears to often require a second determinant for expression-either a second dose of the DR3-associated determinant (6) or, more often, a DR4-associated determinant. The DR3-associated determinant seems to be synergistic with the DR4-associated determinant (7, 8) . In these respects, the DR3-associated determinant shows recessive characteristics. The increased expression of a disease in a mixed heterozygote ( 
